Biota Holdings Limited
Drug discovery company announces 8% revenue growth over prior year
Published in Lab Business Week, September 26th, 2004
Revenues of $8.0M grew by 8% from the prior period (2003 $7.4M). This was primarily due to increased profit share revenues from diagnostic sales by Thermo Electron of $3.5M, up 117% from 2003.
Profit share was generated by sales of the FLU OIA diagnostic product, as well as a new FLU OIA A/B diagnostic recently added to the range, and was boosted by the influenza epidemic in the USA during the northern hemisphere winter.
Relenza royalties of $0.6M fell by almost 50% from the prior period payment (2003 $1.1M), due to the ongoing decline...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week
Source: Lab Business Week (2004-09-26)
More Articles from Lab Business Week
- Advanced Neuromodulation Systems, Inc.
Cyberonics acknowledges purchase of $3.5M shares, shows no interest in merger - Agile Therapeutics
Contraceptive patch maker closes $4.5M financing - Akorn, Inc.
Pharmaceutical firm announces $14.1M private placement - Alchemia Limited
Strong cash reserves and planned Nasdaq listing for Australian biotech company - Arcadia Services, Inc.
Critical Home Care reports post-acquisition Q1 results, discusses acquisition - AspenBio, Inc.
Biotech firm announces closing on $1,287,500 private placement - More from this issue of Lab Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
